CRISPRPtpn2

Robert T Manguso1,2,3, Hans W Pope1,3, Margaret D Zimmer1,3

  • 1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

Nature
|July 21, 2017
PubMed
概括

研究人员在小鼠中使用CRISPR-Cas9查,以找到改善癌症免疫治疗的新方法. 在瘤中删除PTPN2基因增强了免疫反应,为癌症治疗提供了潜在的新点.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K